Market Price

24.89 

0.00 0.0%

as of Dec 05 '22

52 Week Range:

24.89 30.16


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Mitsui Chemicals, Inc. engages in the mobility, health care, food and packaging, basic materials, and other businesses. The company's Mobility segment develops elastomers, performance compounds, functional polymers, polypropylene compounds, and performance polymers; and offers services related to the development of automotive and industrial products. Its Health Care segment offers vision care materials, nonwoven fabrics, dental materials, and personal care materials. The Food & Packaging segment provides coating and engineering materials, performance films and sheets, and agrochemical products. The Basic Materials segment provides ethylene, propylene, polyethylene, polypropylene, catalysts, phenols, purified terephthalic acid, PET, polyurethane materials, and industrial chemical products. The company also offers civil engineering and construction materials; cosmetics; wood adhesives, paper resins, foliar activator, and other chemical products; polyolefin, urethanes, and synthetic resins and resin films; injection molds and presses; phosphoric acid and fertilizers; spunbonded nonwoven fabrics and synthetic fibers; monomers for optical lenses; and fine chemical products and inorganic chemicals. In addition, it is involved in performance analysis, physical property measurements, and safety tests on chemicals; and placements, temporary works, and insurance and travel services, and consignments, as well as the sale of electronics and information materials. The company sells its products in Japan, China, Asia, the Americas, Europe, and internationally. Mitsui Chemicals, Inc. was founded in 1892 and is headquartered in Tokyo, Japan.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20 Mar '21 Mar '22
Equity (BVPS) 3.86
18.71
18.22
18.78
19.09
24.01
26.68
26.12
growth rate 384.7% -2.6% 1.5% 1.7% 25.8% 5.4% -2.1%
Earnings BIT 172.03
-8.37
24,899.00
42,040.00
70,926.00
100,779.00
103,491.00
93,427.00
68,929.00
81,127.00
132,763.00
growth rate -100.0% 100.0% 68.8% 68.7% 42.1% 2.7% -9.7% -26.2% 17.7% 63.7%
Avg.PE 0.10
27.70
3.41
14.11
8.68
8.68
8.68
8.68
4.59
growth rate 27,600.0% -87.7% 313.8% -38.5% 0.0% 0.0% 0.0% -47.1%
ROA -0.08
-0.63
-1.81
1.21
1.72
5.02
5.17
5.17
2.55
3.81
growth rate 0.0% 0.0% 100.0% 42.2% 191.9% 3.0% 0.0% -50.7% 49.4%
ROE -0.27
-2.19
-6.89
4.55
5.83
15.59
14.90
14.32
7.03
10.19
growth rate 0.0% 0.0% 100.0% 28.1% 167.4% -4.4% -3.9% -50.9% 45.0%
ROIC 0.48
-0.38
-2.19
2.33
3.01
7.93
8.06
7.87
3.80
5.57
growth rate -100.0% 0.0% 100.0% 29.2% 163.5% 1.6% -2.4% -51.7% 46.6%
Cur. Ratio 1.46
1.45
1.53
1.63
1.72
1.73
1.69
1.71
1.63
1.69
growth rate -0.7% 5.5% 6.5% 5.5% 0.6% -2.3% 1.2% -4.7% 3.7%
Quick Ratio 0.87
0.83
0.90
0.94
1.02
1.03
1.01
1.04
1.00
1.09
growth rate -4.6% 8.4% 4.4% 8.5% 1.0% -1.9% 3.0% -3.9% 9.0%
Leverage 3.42
3.55
4.06
3.48
3.30
2.95
2.83
2.72
2.81
2.56
growth rate 3.8% 14.4% -14.3% -5.2% -10.6% -4.1% -3.9% 3.3% -8.9%
Balance Sheet Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20 Mar '21 Mar '22
Acct.Receivable 273,929.00
363,940.00
385,397.00
369,212.00
289,459.00
323,454.00
366,582.00
365,161.00
327,782.00
288,152.00
383,635.00
growth rate 32.9% 5.9% -4.2% -21.6% 11.7% 13.3% -0.4% -10.2% -12.1% 33.1%
Acct.Payable 215,666.00
219,849.00
164,193.00
118,331.00
145,658.00
162,179.00
163,908.00
128,458.00
119,712.00
174,844.00
growth rate 1.9% -25.3% -27.9% 23.1% 11.3% 1.1% -21.6% -6.8% 46.1%
Cur.Assets 661,311.00
715,396.00
777,015.00
731,708.00
628,210.00
678,938.00
749,552.00
786,677.00
781,347.00
787,572.00
1,033,445.00
growth rate 8.2% 8.6% -5.8% -14.1% 8.1% 10.4% 5.0% -0.7% 0.8% 31.2%
Total Assets 1,256,303.00
1,337,995.00
1,432,162.00
1,411,790.00
1,258,948.00
1,325,525.00
1,444,104.00
1,501,074.00
1,480,067.00
1,558,125.00
1,934,965.00
growth rate 6.5% 7.0% -1.4% -10.8% 5.3% 9.0% 4.0% -1.4% 5.3% 24.2%
Cash 54,340.00
46,514.00
71,979.00
52,004.00
79,578.00
84,120.00
80,209.00
111,056.00
149,348.00
195,987.00
181,152.00
growth rate -14.4% 54.8% -27.8% 53.0% 5.7% -4.7% 38.5% 34.5% 31.2% -7.6%
Inventory 248,397.00
284,643.00
301,158.00
291,295.00
240,686.00
247,544.00
274,342.00
301,890.00
288,006.00
258,814.00
369,009.00
growth rate 14.6% 5.8% -3.3% -17.4% 2.9% 10.8% 10.0% -4.6% -10.1% 42.6%
Cur.Liabilities 451,507.00
493,908.00
507,056.00
448,499.00
364,259.00
392,783.00
443,198.00
458,758.00
478,498.00
465,763.00
706,569.00
growth rate 9.4% 2.7% -11.6% -18.8% 7.8% 12.8% 3.5% 4.3% -2.7% 51.7%
Liabilities 888,867.00
909,081.00
1,022,515.00
940,491.00
815,711.00
810,890.00
857,500.00
869,335.00
872,046.00
875,968.00
1,127,843.00
growth rate 2.3% 12.5% -8.0% -13.3% -0.6% 5.8% 1.4% 0.3% 0.5% 28.8%
LT Debt 294,501.00
320,956.00
389,595.00
368,996.00
339,299.00
304,228.00
305,963.00
321,288.00
309,787.00
293,496.00
319,471.00
growth rate 9.0% 21.4% -5.3% -8.1% -10.3% 0.6% 5.0% -3.6% -5.3% 8.9%
Equity 367,436.00
376,779.00
352,843.00
406,235.00
381,971.00
449,692.00
511,124.00
551,915.00
527,589.00
607,921.00
712,654.00
growth rate 2.5% -6.4% 15.1% -6.0% 17.7% 13.7% 8.0% -4.4% 15.2% 17.2%
Common Shares 200.00
200.00
200.00
200.00
200.00
200.00
125,125.00
125,205.00
125,298.00
125,331.00
125,414.00
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 62,462.5% 0.1% 0.1% 0.0% 0.1%
Cash Flow Statement Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20 Mar '21 Mar '22
Capital Expenditures 37,109.00
50,050.00
52,096.00
35,091.00
40,046.00
39,530.00
49,587.00
53,191.00
71,896.00
74,904.00
107,067.00
growth rate 34.9% 4.1% -32.6% 14.1% -1.3% 25.4% 7.3% 35.2% 4.2% 42.9%
Cash Dividends 6,011.00
6,011.00
6,009.00
2,002.00
7,006.00
9,005.00
18,007.00
18,878.00
19,509.00
19,349.00
20,527.00
growth rate 0.0% 0.0% -66.7% 250.0% 28.5% 100.0% 4.8% 3.3% -0.8% 6.1%
Cash From OA 43,287.00
18,512.00
43,476.00
58,287.00
145,913.00
100,440.00
82,660.00
109,492.00
114,974.00
174,323.00
92,584.00
growth rate -57.2% 134.9% 34.1% 150.3% -31.2% -17.7% 32.5% 5.0% 51.6% -46.9%
FCF per Share -0.64
-1.03
3.90
3.82
1.92
2.91
4.30
growth rate 0.0% 100.0% -2.1% -49.7% 23.1% 47.8%
Sale Purchase of Stock 8.00
6.00
7.00
1.00
growth rate -25.0% 16.7% -85.7%
FCF 6,193.00
-33,575.00
-10,016.00
20,811.00
104,527.00
58,942.00
29,988.00
53,737.00
38,632.00
97,742.00
-14,483.00
growth rate -100.0% 0.0% 100.0% 402.3% -43.6% -49.1% 79.2% -28.1% 153.0% -100.0%
Income Statement Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20 Mar '21 Mar '22
Sales 1,454,024.00
1,406,220.00
1,566,046.00
1,550,076.00
1,343,898.00
1,212,282.00
1,328,526.00
1,482,909.00
1,338,987.00
1,211,725.00
1,612,688.00
growth rate -3.3% 11.4% -1.0% -13.3% -9.8% 9.6% 11.6% -9.7% -9.5% 33.1%
Op.Income 15,798.00
-7,622.00
24,899.00
42,040.00
70,926.00
100,779.00
103,491.00
93,427.00
68,929.00
81,127.00
132,763.00
growth rate -100.0% 100.0% 68.8% 68.7% 42.1% 2.7% -9.7% -26.2% 17.7% 63.7%
IBT 16,353.00
-796.00
-10,538.00
35,840.00
41,302.00
85,772.00
94,208.00
105,297.00
68,460.00
74,243.00
141,274.00
growth rate -100.0% 0.0% 100.0% 15.2% 107.7% 9.8% 11.8% -35.0% 8.5% 90.3%
Net Income -1,007.00
-7,622.00
-25,138.00
17,261.00
22,963.00
64,839.00
71,585.00
76,115.00
37,944.00
57,873.00
109,990.00
growth rate 0.0% 0.0% 100.0% 33.0% 182.4% 10.4% 6.3% -50.2% 52.5% 90.1%
EPS -5.05
-40.70
-125.50
86.20
114.75
324.05
358.38
385.60
174.52
298.00
growth rate 0.0% 0.0% 100.0% 33.1% 182.4% 10.6% 7.6% -54.7% 70.8%
Gross Profit 192,823.00
172,917.00
212,510.00
241,534.00
274,447.00
293,014.00
309,366.00
316,332.00
297,147.00
293,842.00
378,740.00
growth rate -10.3% 22.9% 13.7% 13.6% 6.8% 5.6% 2.3% -6.1% -1.1% 28.9%
R&D 33,386.00
32,396.00
31,493.00
30,777.00
33,377.00
35,796.00
36,368.00
33,802.00
38,124.00
growth rate -3.0% -2.8% -2.3% 8.5% 7.3% 1.6% -7.1% 12.8%

Quarterly Statements

Item Name Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Earnings BIT 45,444.00
32,734.00
35,864.00
18,721.00
33,939.00
growth rate -28.0% 9.6% -47.8% 81.3%
Balance Sheet Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Acct.Receivable 293,636.00
298,964.00
353,012.00
383,635.00
389,272.00
growth rate 1.8% 18.1% 8.7% 1.5%
Acct.Payable 137,880.00
147,610.00
178,428.00
174,844.00
205,269.00
growth rate 7.1% 20.9% -2.0% 17.4%
Cur.Assets 843,077.00
903,264.00
1,021,582.00
1,033,445.00
1,133,309.00
growth rate 7.1% 13.1% 1.2% 9.7%
Total Assets 1,626,036.00
1,692,448.00
1,856,752.00
1,934,965.00
2,052,115.00
growth rate 4.1% 9.7% 4.2% 6.1%
Cash 215,682.00
196,786.00
211,815.00
181,152.00
190,868.00
growth rate -8.8% 7.6% -14.5% 5.4%
Inventory 285,564.00
310,498.00
342,008.00
369,009.00
433,405.00
growth rate 8.7% 10.2% 7.9% 17.5%
Cur.Liabilities 469,465.00
512,078.00
647,197.00
706,569.00
800,760.00
growth rate 9.1% 26.4% 9.2% 13.3%
Liabilities 906,161.00
927,719.00
1,073,023.00
1,127,843.00
1,206,668.00
growth rate 2.4% 15.7% 5.1% 7.0%
LT Debt 322,974.00
311,134.00
320,733.00
319,471.00
304,255.00
growth rate -3.7% 3.1% -0.4% -4.8%
Equity 645,058.00
677,741.00
691,085.00
712,654.00
749,566.00
growth rate 5.1% 2.0% 3.1% 5.2%
Common Shares 125,331.00
125,414.00
125,414.00
125,414.00
125,414.00
growth rate 0.1% 0.0% 0.0% 0.0%
Cash Flow Statement Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Capital Expenditures 23,157.00
21,278.00
32,384.00
30,248.00
31,537.00
growth rate -8.1% 52.2% -6.6% 4.3%
Cash Dividends 9,797.00
10,730.00
10,730.00
12,560.00
12,560.00
growth rate 9.5% 0.0% 17.1% 0.0%
Cash From OA 28,653.00
33,963.00
-8,279.00
38,247.00
-10,642.00
growth rate 18.5% -100.0% 100.0% -100.0%
FCF 5,496.00
12,685.00
-40,663.00
7,999.00
-42,179.00
growth rate 130.8% -100.0% 100.0% -100.0%
Income Statement Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Sales 370,591.00
372,944.00
421,544.00
447,609.00
476,113.00
growth rate 0.6% 13.0% 6.2% 6.4%
Op.Income 45,444.00
32,734.00
35,864.00
18,721.00
33,939.00
growth rate -28.0% 9.6% -47.8% 81.3%
IBT 51,885.00
40,471.00
37,223.00
11,695.00
40,819.00
growth rate -22.0% -8.0% -68.6% 249.0%
Net Income 42,624.00
31,316.00
26,127.00
9,923.00
27,992.00
growth rate -26.5% -16.6% -62.0% 182.1%
EPS
growth rate
Gross Profit 99,546.00
89,678.00
94,244.00
95,272.00
104,587.00
growth rate -9.9% 5.1% 1.1% 9.8%
R&D 38,124.00
38,124.00
38,124.00
38,124.00
growth rate 0.0% 0.0% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (24.27)

YOY Growth Grade:

E (27.18)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 12.00 12.00
EPS / Growth 2.08

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 10.3%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 10.3% 10.3% 10.3%
Future PE 0.01 10.89 10.89
Future EPS 5.55 5.55 5.55
Value Price
MOS %
0.01
-99.9%
14.93
-40.0%
14.93
-40.0%
MOS Price 0.01 7.46 7.46
IRT 7.65 7.65 7.65

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.